Importantly, the therapy facilitated a substantial reduction in prednisone dosage at 6, 12, and 24 weeks, underscoring its steroid-sparing potential
The results showed that Novo's drug, CagriSema, promoted slightly less weight loss than Zepbound at 84 weeks in the study a difference that puts the sales potential of the experimental treatment into question
Neurological research represents another frontier for BPC-157 investigations
Overexpression of enhanced yellow fluorescent protein fused with Channelrhodopsin-2 causes contractile dysfunction in skeletal muscle
Lab visits average 15 minutes
In emailed statements, Seit said his aim is "always directed at optimizing my patients' care and treatment and that he is permitted to compound BPC-157 as a natural health product (NHP), which Health Canada confirmed